NCT07271420RecruitingPhase 4
Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 26 Nov 2025
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Chinese University of Hong Kong
- NCT number
- NCT07271420
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 40
- From 1 Jan 2020 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months
Who the study is looking for
- Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \>140 mmHg and/or DBP \>90 mmHg)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital / The Chinese University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.